Cara Therapeutics Statistics
Total Valuation
CARA has a market cap or net worth of $18.84 million. The enterprise value is -$5.52 million.
| Market Cap | 18.84M |
| Enterprise Value | -5.52M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CARA has 54.68 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Shares Outstanding | 54.68M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 15.25% |
| Owned by Institutions (%) | 40.50% |
| Float | 46.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.11 |
| Forward PS | 3.40 |
| PB Ratio | 0.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.38, with a Debt / Equity ratio of 1.52.
| Current Ratio | 5.38 |
| Quick Ratio | 4.77 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.39 |
Financial Efficiency
Return on equity (ROE) is -174.20% and return on invested capital (ROIC) is -164.19%.
| Return on Equity (ROE) | -174.20% |
| Return on Assets (ROA) | -105.30% |
| Return on Capital (ROIC) | -164.19% |
| Revenue Per Employee | $307,964 |
| Profits Per Employee | -$2.23M |
| Employee Count | 55 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.92% in the last 52 weeks. The beta is 0.69, so CARA's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -88.92% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.80 |
| Relative Strength Index (RSI) | 45.02 |
| Average Volume (20 Days) | 1,592,869 |
Short Selling Information
The latest short interest is 1.93 million, so 3.53% of the outstanding shares have been sold short.
| Short Interest | 1.93M |
| Short Previous Month | 2.27M |
| Short % of Shares Out | 3.53% |
| Short % of Float | 4.13% |
| Short Ratio (days to cover) | 1.47 |
Income Statement
In the last 12 months, CARA had revenue of $16.94 million and -$122.54 million in losses. Loss per share was -$2.26.
| Revenue | 16.94M |
| Gross Profit | 12.73M |
| Operating Income | -123.51M |
| Pretax Income | -122.54M |
| Net Income | -122.54M |
| EBITDA | -117.75M |
| EBIT | -119.96M |
| Loss Per Share | -$2.26 |
Balance Sheet
The company has $69.77 million in cash and $45.42 million in debt, giving a net cash position of $24.35 million or $0.45 per share.
| Cash & Cash Equivalents | 69.77M |
| Total Debt | 45.42M |
| Net Cash | 24.35M |
| Net Cash Per Share | $0.45 |
| Equity (Book Value) | 29.80M |
| Book Value Per Share | 0.55 |
| Working Capital | 66.13M |
Cash Flow
In the last 12 months, operating cash flow was -$87.91 million and capital expenditures -$3.21 million, giving a free cash flow of -$91.12 million.
| Operating Cash Flow | -87.91M |
| Capital Expenditures | -3.21M |
| Free Cash Flow | -91.12M |
| FCF Per Share | -$1.67 |
Margins
Gross margin is 75.18%, with operating and profit margins of -729.19% and -723.49%.
| Gross Margin | 75.18% |
| Operating Margin | -729.19% |
| Pretax Margin | -723.49% |
| Profit Margin | -723.49% |
| EBITDA Margin | -695.16% |
| EBIT Margin | -708.22% |
| FCF Margin | -537.99% |
Dividends & Yields
CARA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | -650.59% |
| FCF Yield | -483.78% |
Analyst Forecast
The average price target for CARA is $1.00, which is 190.28% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.00 |
| Price Target Difference | 190.28% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 25.59% |
| EPS Growth Forecast (5Y) | -21.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CARA has an Altman Z-Score of -14.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.25 |
| Piotroski F-Score | 1 |